The global biocompatible coatings market size is projected to grow from USD 14.6 billion in 2022 to USD 29.7 billion by 2028, at a CAGR of 12.4%. The demand for biocompatible coatings is influenced by several factors. One crucial factor is the increasing focus on healthcare and medical advancements. With the continuous progress in medical technology and the growing emphasis on patient well-being, there is a higher demand for biocompatible coatings in various applications. These coatings play a vital role in enhancing the biocompatibility of medical devices, implants, and prosthetics, reducing the risk of adverse reactions and improving patient outcomes. The aging population and the prevalence of chronic diseases drive the demand for medical devices and implants, which, in turn, fuels the demand for biocompatible coatings. The companies have adopted various strategies, such as mergers & acquisitions, investment & expansion, joint ventures, & new product launches and to increase their global presence and maintain sustained growth in the biocompatible coatings market.
Asia Pacific, comprising countries such as China, Japan, India, South Korea, and Southeast Asian nations, is witnessing rapid industrialization, urbanization, and economic growth. This development has led to increased investments in healthcare infrastructure and medical advancements, driving the demand for biocompatible coatings. The region's large population, particularly the aging demographic, further fuels the need for medical devices, implants, and prosthetics, which require biocompatible coatings to ensure compatibility and performance.
To know about the assumptions considered for the study download the pdf brochure
The Middle East, countries such as the United Arab Emirates (UAE), Saudi Arabia, and Qatar have been investing heavily in healthcare infrastructure and medical tourism. These nations are becoming regional hubs for medical treatments and procedures, attracting patients from around the world. Consequently, the demand for biocompatible coatings in the Middle East is driven by the need for high-quality medical devices, implants, and prosthetics that meet international standards.
The major players in the global biocompatible coatings market are SurModics, Inc. (US), DSM Biomedical (US), Hydromer Inc. (US), Covalon Technologies Ltd. (Canada), and Hemoteq AG (Germany). These players opted for inorganic growth through mergers & acquisitions, agreements, and partnerships. For instance, in July 2021, SurModics, Inc. has acquired privately-held Vetex Medical Limited. The Galway, Ireland-based medical device developer and manufacturer has focused exclusively on venous clot removal solutions.
SurModics, Inc: SurModics, Inc. is a global provider of surface modification and in vitro diagnostic technologies. The company is headquartered in Eden Prairie, Minnesota, United States. SurModics has been operating for over four decades and has established itself as a leader in the field of biocompatible coatings and surface modification technologies. The company's core focus is on developing and commercializing innovative solutions that enhance the performance, biocompatibility, and functionality of medical devices. SurModics offers a broad portfolio of biocompatible coatings designed to address various applications and industries, including cardiovascular, ophthalmology, neurology, and in-vitro diagnostics. SurModics' biocompatible coatings provide functionalities such as lubricity, hydrophilicity, drug delivery, anti-thrombogenicity, and bioactive capabilities. These coatings are tailored to meet the specific requirements of medical devices, ensuring improved performance, reduced complications, and enhanced patient outcomes. SurModics collaborates with medical device manufacturers, pharmaceutical companies, and diagnostic testing laboratories to develop customized coating and surface modification solutions. The company's team of scientists and engineers work closely with customers to understand their specific needs and deliver innovative solutions that address their challenges.
In April 2020, Cook Medical and Surmodics, Inc. have announced a new distribution agreement in which Cook Medical will market two novel Surmodics products, hydrophilic percutaneous transluminal angioplasty (PTA) balloon catheters that may be utilised beyond 0.014-inch and 0.018-inch wire guides.
DSM Biomedical: DSM Biomedical is a division of DSM, a global science-based company headquartered in the Netherlands. DSM Biomedical specializes in developing and manufacturing biomedical materials and technologies, with a focus on providing innovative solutions for the medical device and healthcare industries. The company offers a wide range of products and solutions that address various medical applications, including orthopedics, cardiovascular devices, dental applications, drug delivery systems, and wound care. DSM Biomedical's expertise lies in developing biocompatible materials, coatings, drug delivery systems, and regenerative solutions that enhance the performance, biocompatibility, and safety of medical devices. The company places a strong emphasis on sustainability and environmental responsibility. DSM Biomedical strives to develop materials and technologies that are eco-friendly and have minimal impact on the environment. This commitment aligns with the growing demand for sustainable solutions in the medical industry.
In January 2021, DSM Biomedical and NC Biomatrix sign Memorandum of Understanding for the development of breakthrough regenerative devices for the treatment of back pain.
Biocompatible Coatings Market by Type (Antibacterial, hydrophilic), Material (Polymer, Ceramics, Metal), End-Use Industry (Healthcare, Food & Beverage, Medical Devices), & Region (APAC, Europe, North America, MEA & SA) - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE